A detailed history of Garrett Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Garrett Investment Advisors LLC holds 1,854 shares of ABBV stock, worth $305,891. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,854
Previous 1,742 6.43%
Holding current value
$305,891
Previous $298,000 22.82%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $18,350 - $22,324
112 Added 6.43%
1,854 $366,000
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $9,132 - $10,664
-59 Reduced 3.28%
1,742 $298,000
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $81,508 - $92,871
-510 Reduced 22.07%
1,801 $327,000
Q4 2023

Jan 05, 2024

SELL
$137.6 - $154.97 $395,462 - $445,383
-2,874 Reduced 55.43%
2,311 $358,000
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $120,498 - $139,494
902 Added 21.06%
5,185 $772,000
Q2 2023

Jul 10, 2023

BUY
$132.51 - $164.9 $12,455 - $15,500
94 Added 2.24%
4,283 $577,000
Q1 2023

Apr 04, 2023

BUY
$144.61 - $166.54 $64,496 - $74,276
446 Added 11.92%
4,189 $667,000
Q4 2022

Jan 09, 2023

SELL
$138.31 - $165.87 $6,915 - $8,293
-50 Reduced 1.32%
3,743 $0
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $27,110 - $31,093
202 Added 5.63%
3,793 $509,000
Q1 2022

Apr 04, 2022

SELL
$131.98 - $163.75 $96,081 - $119,210
-728 Reduced 16.86%
3,591 $582,000
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $261,699 - $331,125
2,436 Added 129.37%
4,319 $585,000
Q1 2021

Apr 20, 2021

SELL
$102.3 - $112.62 $1,125 - $1,238
-11 Reduced 0.58%
1,883 $204,000
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $152,448 - $205,820
1,894 New
1,894 $203,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Garrett Investment Advisors LLC Portfolio

Follow Garrett Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrett Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrett Investment Advisors LLC with notifications on news.